Neurocognitive impairment in children and adolescents with systemic lupus erythematosus

Nature Clinical Practice Rheumatology

Volumn 5, Issue 2, 2009, Pages 106-114

  Levy, Deborah M ^a   Ardoin, Stacy P ^b   Schanberg, Laura E ^b  

^a Department of Medicine   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMANTINE; PLACEBO;

AGE DISTRIBUTION; BRAIN FUNCTION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL TRIAL; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DOSE RESPONSE; HUMAN; LABORATORY TEST; MAGNETIC RESONANCE ANGIOGRAPHY; MEMORY; MENTAL DEVELOPMENT; MENTAL HEALTH CARE; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; CHILD; COGNITION; COGNITION DISORDERS; COMORBIDITY; DIAGNOSTIC IMAGING; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; NEUROPSYCHOLOGICAL TESTS;

EID: 59849091572     PISSN: 17458382     EISSN: 17458390     Source Type: Journal    
DOI: 10.1038/ncprheum0988     Document Type: Review

References (65)

1. The American College of Rheumatology (1999) The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 42: 599-608
2. Sibbitt WL Jr et al. (2002) The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol 29: 1536-1542
3. Hiraki LT et al. (2008) Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: A longitudinal study. J Pediatr 152: 550-556
4. Brunner HI et al. (2007) Initial validation of the Pediatric Automated Neuropsychological Assessment Metrics for childhood-onset systemic lupus erythematosus. Arthritis Rheum 57: 1174-1182
5. Mikdashi JA et al. (2007) Proposed response criteria for neurocognitive impairment in systemic lupus erythematosus clinical trials. Lupus 16: 418-425
6. Ainiala H et al. (2001) The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology 57: 496-500
7. Glanz BI et al. (1997) Pattern of neuropsychologic dysfunction in inactive systemic lupus erythematosus. Neuropsychiatry Neuropsychol Behav Neurol 10: 232-238
8. Denburg SD et al. (1987) Cognitive impairment in systemic lupus erythematosus: A neuropsychological study of individual and group deficits. J Clin Exp Neuropsychol 9: 323-339
9. Kozora E et al. (1996) Analysis of cognitive and psychological deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum 39: 2035-2045
10. Shucard JL et al. (2004) Working memory and processing speed deficits in systemic lupus erythematosus as measured by the paced auditory serial addition test. J Int Neuropsychol Soc 10: 35-45
11. Ginsburg KS et al. (1992) A controlled study of the prevalence of cognitive dysfunction in randomly selected patients with systemic lupus erythematosus. Arthritis Rheum 35: 776-782
12. Hanly JG et al. (1992) Cognitive impairment in patients with systemic lupus erythematosus. J Rheumatol 19: 562-567
13. McLaurin EY et al. (2005) Predictors of cognitive dysfunction in patients with systemic lupus erythematosus. Neurology 64: 297-303
14. Harel L et al. (2006) Neuropsychiatric manifestations in pediatric systemic lupus erythematosus and association with antiphospholipid antibodies. J Rheumatol 33: 1873-1877
15. Avcin T et al. (2008) A followup study of antiphospholipid antibodies and associated neuropsychiatric manifestations in 137 children with systemic lupus erythematosus. Arthritis Rheum 59 206-213
16. Emori A et al. (2005) Cognitive dysfunction in systemic lupus erythematosus. Psychiatry Clin Neurosci 59: 584-589
17. Benedict RH et al. (2008) Neuropsychological impairment in systemic lupus erythematosus: A comparison with multiple sclerosis. Neuropsychol Rev 18: 149-166
18. Carbotte RM et al. (1995) Cognitive deficit associated with rheumatic diseases: Neuropsychological perspectives. Arthritis Rheum 38: 1363-1374
19. Wyckoff PM et al. (1995) Neuropsychological assessment of children and adolescents with systemic lupus erythematosus. Lupus 4: 217-220
20. Ardoin SP et al. (2008) Retrospective analysis of neurocognitive testing in children and adolescents with SLE. Arthritis Rheum (in press)
21. Filley CM (2005) White matter and behavioral neurology. Ann NY Acad Sci 1064: 162-183
22. Filley CM (1998) The behavioral neurology of cerebral white matter. Neurology 50: 1535-1540
23. Luna B et al. (2004) Maturation of cognitive processes from late childhood to adulthood. Child Dev 75: 1357-1372
24. Luna B and Sweeney JA (2001) Studies of brain and cognitive maturation through childhood and adolescence: A strategy for testing neurodevelopmental hypotheses. Schizophr Bull 27: 443-455
25. Korkman M et al. (2001) Effects of age on neurocognitive measures of children ages 5 to 12: A cross-sectional study on 800 children from the United States. Dev Neuropsychol 20: 331-354
26. Devinsky O et al. (1988) Clinical and neuropathological findings in systemic lupus erythematosus: The role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura. Ann Neurol 23: 380-384
27. Ellis SG and Verity MA (1979) Central nervous system involvement in systemic lupus erythematosus: A review of neuropathologic findings in 57 cases, 1955-1977. Semin Arthritis Rheum 8: 212-221
28. Kang EH et al. (2008) Flow cytometric assessment of anti-neuronal antibodies in central nervous system involvement of systemic lupus erythematosus and other autoimmune diseases. Lupus 17: 21-25
29. Papero PH et al. (1990) Neuropsychologic deficits and antineuronal antibodies in pediatric systemic lupus erythematosus. Clin Exp Rheumatol 8: 417-424
30. Zandman-Goddard G et al. (2007) Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome. Semin Arthritis Rheum 36: 297-315
31. Benseler SM and Silverman ED (2007) Neuropsychiatric involvement in pediatric systemic lupus erythematosus. Lupus 16: 564-571
32. Toubi E and Shoenfeld Y (2007) Clinical and biological aspects of anti-P-ribosomal protein autoantibodies. Autoimmun Rev 6: 119-125
33. Katzav A et al. (2007) Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system. Arthritis Rheum 56: 938-948
34. Hanly JG et al. (1999) A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus. Arthritis Rheum 42: 728-734
35. DeGiorgio LA et al. (2001) A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 7: 1189-1193
36. Kowal C et al. (2004) Cognition and immunity; antibody impairs memory. Immunity 21: 179-188
37. Yoshio T et al. (2006) Association of IgG anti-NR2 glutamate receptor antibodies in cerebrospinal fluid with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 54: 675-678
38. Levy D (2007) Anti-NR-2 antibodies are prevalent in childhood-onset SLE (cSLE), but do not predict neurocognitive dysfunction [abstract]. Arthritis Rheum 55: S143
39. Iikuni N et al. (2006) Raised monocyte chemotactic protein-1 (MCP-1)/CCL2 in cerebrospinal fluid of patients with neuropsychiatric lupus. Ann Rheum Dis 65: 253-256
40. Fragoso-Loyo H et al. (2007) Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus. Arthritis Rheum 56: 1242-1250
41. Hanly JG et al. (2005) Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis. J Rheumatol 32: 1459-1466
42. Ouvrier RA et al. (1993) The value of the Mini-Mental State Examination in childhood: A preliminary study. J Child Neurol 8 145-148
43. Brunner HI et al. (2008) Standardizing the neuropsychological evaluation of children with SLE [abstract]. Lupus 17: 467
44. Levy DM et al. (2007) Neurocognitive function in childhood-onset systemic lupus erythematosus [abstract]. Arthritis Rheum 56: S368
45. Reeves DL et al. (2007) ANAM genogram: Historical perspectives, description, and current endeavors. Arch Clin Neuropsychol 22 (suppl 1): S15-S37
46. Kane RL et al. (2007) Identifying and monitoring cognitive deficits in clinical populations using Automated Neuropsychological Assessment Metrics (ANAM) tests. Arch Clin Neuropsychol 22 (suppl 1): S115-S126
47. Roebuck-Spencer TM et al. (2006) Use of computerized assessment to predict neuropsychological functioning and emotional distress in patients with systemic lupus erythematosus. Arthritis Rheum 55 434-441
48. Holliday SL et al. (2003) Validating a computerized neuropsychological test battery for mixed ethnic lupus patients. Lupus 12: 697-703
49. Sibbitt WL Jr et al. (1999) Neuroimaging in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 42: 2026-2038
50. Jennings JE et al. (2004) Value of MRI of the brain in patients with systemic lupus erythematosus and neurologic disturbance. Neuroradiology 46: 15-21
51. Ainiala H et al. (2005) Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: A population-based study. Scand J Rheumatol 34: 376-382
52. Kozora E et al. (1998) Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum 41: 41-47
53. Kao CH et al. (1999) The role of FDG-PET, HMPAOSPET and MRI in the detection of brain involvement in patients with systemic lupus erythematosus. Eur J Nucl Med 26: 129-134
54. Weiner SM et al. (2000) Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: Value of F-18 fluorodeoxyglucose PET. Ann Rheum Dis 59: 377-385
55. Sabbadini MG et al. (1999) Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations. Lupus 8: 11-19
56. Waterloo K et al. (2001) Neuropsychological dysfunction in systemic lupus erythematosus is not associated with changes in cerebral blood flow. J Neurol 248: 595-602
57. Kozora E et al. (2005) Cognition, MRS neurometabolites, and MRI volumetrics in non-neuropsychiatric systemic lupus erythematosus: preliminary data. Cogn Behav Neurol 18: 159-162
58. Brooks WM et al. (1999) Relationship between neurometabolite derangement and neurocognitive dysfunction in systemic lupus erythematosus. J Rheumatol 26: 81-85
59. Bosma GP et al. (2000) Detection of cerebral involvement in patients with active neuropsychiatric systemic lupus erythematosus by the use of volumetric magnetization transfer imaging. Arthritis Rheum 43: 2428-2436
60. Rovaris M et al. (2000) Brain involvement in systemic immune mediated diseases: Magnetic resonance and magnetisation transfer imaging study. J Neurol Neurosurg Psychiatry 68: 170-177
61. Emmer BJ et al. (2006) Detection of change in CNS involvement in neuropsychiatric SLE: A magnetization transfer study. J Magn Reson Imaging 24: 812-816
62. Emmer BJ et al. (2008) Correlation of magnetization transfer ratio histogram parameters with neuropsychiatric systemic lupus erythematosus criteria and proton magnetic resonance spectroscopy: Association of magnetization transfer ratio peak height with neuronal and cognitive dysfunction. Arthritis Rheum 58: 1451-1457
63. DiFrancesco MW et al. (2007) Functional magnetic resonance imaging assessment of cognitive function in childhood-onset systemic lupus erythematosus: A pilot study. Arthritis Rheum 56: 4151-4163
64. Naqibuddin M et al. (2007) Memantine in systemic lupus erythematosus: A randomized double-blind, placebo-controlled trial [abstract]. Arthritis Rheum 56 (suppl 9): S528
65. Harrison MJ et al. (2005) Results of intervention for lupus patients with self-perceived cognitive difficulties. Neurology 65: 1325-1327